The 2027 DCLF agenda is currently being developed around the most consequential issues shaping the drug channel. The full agenda will be announced this fall. In the meantime, explore the 2026 agenda for a look at the caliber of topics, speakers, and discussions you can expect at DCLF.

Monday, March 16, 2026

5:00 PM - 7:00 PM
Welcome Cocktail Reception

Tuesday, March 17, 2026

7:30 AM - 8:30 AM
Breakfast
8:30 AM - 8:45 AM
Conference Welcome Remarks
  • Paula B. Fein, MSEd
    Vice President | Drug Channels Institute
8:45 AM - 9:15 AM
Keynote: The State of the Drug Channel 2026
  • Adam J. Fein, PhD
    President | Drug Channels Institute
9:15 AM - 10:00 AM
Fireside Chat with Debbie Weitzman
  • Panelist
    Debbie Weitzman
    CEO, Pharmaceutical & Specialty Solutions | Cardinal Health
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
10:00 AM - 10:15 AM
Coffee Break
10:15 AM - 11:00 AM
Wall Street Controversies on Drug Channel Companies
  • Elizabeth Anderson Headshot
    Panelist
    Elizabeth Anderson, MBA
    Senior Managing Director | Evercore ISI
  • Cherny headshot
    Panelist
    Michael Cherny
    Senior Managing Director | Leerink Partners
  • George Headshot
    Panelist
    George Hill
    Managing Director & Lead Analyst, Healthcare Technology & Service | Deutsche Bank Securities Inc.
  • Tyler Headshot
    Moderator
    Tyler Novotny
    Senior Vice President | Drug Channels Institute
11:00 AM - 11:45 AM
What's Next for Provider-Administered Drugs and Buy-and-Bill
  • Jan headshot
    Panelist
    Saira A. Jan, MS, PharmD
    Vice President & Chief Pharmacy Officer | Horizon Blue Cross Blue Shield of New Jersey
  • Panelist
    Debra Patt, MD, PhD, MBA
    Executive Vice President, Policy and Strategy | Texas Oncology
  • Thompson Smith headshot
    Panelist
    Lisa Thompson Smith, RPh
    SVP & President, Specialty Distribution and Solutions | Cencora
  • Sullivan headshot
    Moderator
    Milena Sullivan
    Partner, Market Access | Blue Matter Consulting
11:45 AM - 1:00 PM
Lunch
1:00 PM - 2:00 PM
Keynote + Fireside Chat with Eric Percher
  • Percher headshot
    Keynote Speakear
    Eric Percher
    Co-Founder Nephron Research, Lead Analyst Drug Channel & Digital Health | Nephron Research
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
2:00 PM - 2:45 PM
Fireside Chat with Mostafa Kamal
  • Panelist
    Mostafa Kamal
    President and Chief Executive Officer | Prime Therapeutics
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
2:45 PM - 3:00 PM
Coffee Break
3:00 PM - 3:45 PM
Crossfire: The 340B Drug Pricing Program
  • john o'brien
    Panelist
    John M. O'Brien, PharmD, MPH
    President and Chief Executive Officer | National Pharmaceutical Council
  • Testoni headshot
    Panelist
    Maureen Testoni, JD
    President and Chief Executive Officer | 340B Health
  • Luke Greenwalt Headshot
    Moderator
    Luke Greenwalt, MBA
    VP and Lead, IQVIA Thought Leadership & Innovation | IQVIA
3:45 PM - 4:30 PM
Fireside Chat with Kevin Host
  • Host Headshot
    Panelist
    Kevin Host, PharmD
    Senior Vice President, Pharmacy | Walmart
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
4:30 PM - 5:15 PM
Fireside Chat with Mark Cuban
  • Mark Cuban Headshot
    Panelist
    Mark Cuban
    Entrepreneur and Co-Founder | Cost Plus Drugs
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
6:00 PM - 8:00 PM
Outdoor Dinner Reception

Wednesday, March 18, 2026

7:30 AM - 8:30 AM
Breakfast
8:30 AM - 9:30 AM
Keynote + Fireside Chat with Antonio Ciaccia
  • Keynote Speaker
    Antonio Ciaccia
    President | 3 Axis Advisors , Chief Executive Officer | 46brooklyn Research
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
9:30 AM - 10:15 AM
The View from the Payer
  • Panelist
    Mike Jansen
    Senior Director, Benefits & Wellbeing | Walmart Stores, Inc.
  • Panelist
    Rosa Novo
    Administrative Benefits Director | Miami-Dade County Public Schools
  • Bryce Platt Headshot
    Moderator
    Bryce Platt, PharmD, RPh
    Director | Drug Channels Institute
10:15 AM - 10:30 AM
Coffee Break
10:30 AM - 11:15 AM
How Patient-Paid Prescriptions are Changing the Drug Channel
  • Laura Jensen headshot
    Panelist
    Laura Jensen, MBA
    Chief Commercial Officer and President of Pharma Solutions | GoodRx
  • Love headshot
    Panelist
    John Love
    Vice President | Amazon Pharmacy
  • Panelist
    Jennifer Mazur, MBA
    General Manager, US LillyDirect; Senior Vice President, Lilly USA Consumer Hub | Eli Lilly and Company
  • Moderator
    Jailendra Singh, MBA
    Managing Director | Truist Securities
11:15 AM - 12:00 PM
The Perspective from Market Access
  • Panelist
    Jeff Davis
    Executive Director, National Channel | AstraZeneca
  • Christine Photo
    Panelist
    Christine G. Marsh, MBA
    Senior Vice President, Value & Access | Boehringer Ingelheim
  • Norton headshot
    Panelist
    Jennifer Norton
    Former Senior Vice President, Patient and Market Access | Takeda Pharmaceuticals
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
12:00 PM - 12:05 PM
Conference Closing Remarks
  • Adam J. Fein, PhD
    President | Drug Channels Institute
Back to top